doi:10.3969/j.issn.1673-8640.2018.06.023

Abstract

CLC Number:

R446.1

Figures/Tables 2

References 12

[1]	尹经霞,廖涌,李伶,等. 锌α2糖蛋白与胰岛素抵抗相关疾病关系的研究进展[J]. 重庆医科大学学报,2015,40(7):914-917.
[2]	刘瑞,杨刚毅,李姝,等. 锌α2糖蛋白与脂联素在不同糖耐量人群的关联性研究[J]. 中华内分泌代谢杂志,2013,29(4):278-281.
[3]	李白洁,范志宏. 锌α2糖蛋白与2型糖尿病关系的研究进展[J]. 中国糖尿病杂志,2016,24(8):757-759.
[4]	陆在英,钟南山. 内科学[M]. 7版. 北京:人民卫生出版社,2008:832.
[5]	石英,邓拥军. 血尿酸水平与代谢综合征患病相关性的研究[J]. 检验医学,2011,26(7):429-432.
[6]	杨洁,刘李文韬,陈秉朴,等. 锌α2糖蛋白与高尿酸血症的相关性研究[J]. 医学研究生学报,2017,30(2):173-176.
[7]	MRACEK T,DING Q,TZANAVARI T,et al.The adipokine zinc-alpha2-glycoprotein(ZAG) is downregulated with fat mass expansion in obesity[J].Clin Endocrinol(Oxf),2009,72(3):334-341.
[8]	解婧,蒋志华,成兴波. 2型糖尿病患者血清锌α2糖蛋白水平的变化及其相关因素分析[J]. 中国糖尿病杂志,2012,20(2):102-104.
[9]	RUSSELL S T,TISDALE M J.Effect of a tumour-derived lipid-mobilising factor on glucose and lipid metabolism in vivo[J]. Br J Cancer,2002,87(5):580-584.
[10]	NÄF S,ESCOTE X,YAÑEZ R E,et al. Zinc-α2-glycoprotein is unrelated to gestational diabetes:anthropometric and metabolic determinants in pregnant women and their offspring[J]. PLoS One,2012,7(12):e47601.
[11]	MODAN M,HALKIN H,KARASIK A,et al.Elevated serum uric acid-a facet of hyperinsulinaemia[J]. Diabetologia,1987,30(9):713-718.
[12]	BALAZ M,VICIAN M,JANAKOVA Z,et al.Subcutaneous adipose tissue zinc-α2-glycoprotein is associated with adipose tissue and whole-body insulin sensitivity[J]. Obesity(Silver Spring),2014,22(8):1821-1829.

组别	例数	BMI（kg/m²）	收缩压（kPa）	舒张压（kPa）	FPG（mmol/L）
单纯T2DM组	220	24.76±4.43^*	18.35±3.42^*	11.47±2.35^*	7.29±1.95^*
T2DM合并HUA组	100	26.43±3.47^*#	18.78±3.56^*	11.51±1.10^*	7.55±1.60^*
正常对照组	80	23.10±4.00	17.03±3.29	10.33±2.06	4.98±0.64
组别	TC（mmol/L）	TG（mmol/L）	LDL-C（mmol/L）	HDL-C（mmol/L）	HbA_1c（%）
单纯T2DM组	4.43±1.34	1.86±1.27^*	2.43±0.78	1.15±0.41^*	8.71±1.36^*
T2DM合并HUA组	4.45±1.16	2.28±0.76^*#	2.44±0.82	1.03±0.35^*#	10.89±2.24^*#
正常对照组	4.41±1.25	1.36±0.89	2.41±0.86	1.32±0.31	5.12±0.34
组别	Cr（μmol/L）	BUN（mmol/L）	UA（μmol/L）	FINS（mU/L）	ZAG（mg/L）
单纯T2DM组	66.62±18.18	5.51±1.34^*	296.27±80.38	10.06±1.78^*	58.89±23.17^*
T2DM合并HUA组	106.50±46.27^*#	6.62±2.90^*#	486.48±75.34^*#	12.69±2.05^*#	86.42±25.36^*#
正常对照组	63.00±13.28	4.86±1.50	289.04±76.13	4.86±3.58	86.42±25.36^*#

组别	例数	BMI（kg/m²）	收缩压（kPa）	舒张压（kPa）	FPG（mmol/L）
单纯T2DM组	220	24.76±4.43^*	18.35±3.42^*	11.47±2.35^*	7.29±1.95^*
T2DM合并HUA组	100	26.43±3.47^*#	18.78±3.56^*	11.51±1.10^*	7.55±1.60^*
正常对照组	80	23.10±4.00	17.03±3.29	10.33±2.06	4.98±0.64
组别	TC（mmol/L）	TG（mmol/L）	LDL-C（mmol/L）	HDL-C（mmol/L）	HbA_1c（%）
单纯T2DM组	4.43±1.34	1.86±1.27^*	2.43±0.78	1.15±0.41^*	8.71±1.36^*
T2DM合并HUA组	4.45±1.16	2.28±0.76^*#	2.44±0.82	1.03±0.35^*#	10.89±2.24^*#
正常对照组	4.41±1.25	1.36±0.89	2.41±0.86	1.32±0.31	5.12±0.34
组别	Cr（μmol/L）	BUN（mmol/L）	UA（μmol/L）	FINS（mU/L）	ZAG（mg/L）
单纯T2DM组	66.62±18.18	5.51±1.34^*	296.27±80.38	10.06±1.78^*	58.89±23.17^*
T2DM合并HUA组	106.50±46.27^*#	6.62±2.90^*#	486.48±75.34^*#	12.69±2.05^*#	86.42±25.36^*#
正常对照组	63.00±13.28	4.86±1.50	289.04±76.13	4.86±3.58	86.42±25.36^*#

变量	回归系数	回归系数标准误	标准回归系数	t值	P值
BMI	3.602	0.654	0.142	5.550	<0.001
TG	6.185	1.339	0.155	6.062	<0.001
HDL-C	-6.438	1.364	0.159	8.246	<0.001

变量	回归系数	回归系数标准误	标准回归系数	t值	P值
BMI	3.602	0.654	0.142	5.550	<0.001
TG	6.185	1.339	0.155	6.062	<0.001
HDL-C	-6.438	1.364	0.159	8.246	<0.001

[1]	FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114.
[2]	SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.
[3]	LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.
[4]	YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.
[5]	XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.
[6]	CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.
[7]	. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.
[8]	. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.
[9]	WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166.
[10]	YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.
[11]	DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.
[12]	GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.
[13]	. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.
[14]	. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.
[15]	. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 2

References 12

Related Articles 15

Recommended Articles

Metrics